| 000 | 01749 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517132746.0 | ||
| 264 | 0 | _c20180220 | |
| 008 | 201802s 0 0 eng d | ||
| 022 | _a1949-2553 | ||
| 024 | 7 |
_a10.18632/oncotarget.14328 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFeng, Jun | |
| 245 | 0 | 0 |
_aProtective effect of tanshinone IIA against cardiac hypertrophy in spontaneously hypertensive rats through inhibiting the Cys-C/Wnt signaling pathway. _h[electronic resource] |
| 260 |
_bOncotarget _cFeb 2017 |
||
| 300 |
_a10161-10170 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAbietanes _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aArginine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aCardiomegaly _xgenetics |
| 650 | 0 | 4 |
_aCardiovascular Agents _xpharmacology |
| 650 | 0 | 4 |
_aCollagen Type I _xgenetics |
| 650 | 0 | 4 | _aCollagen Type I, alpha 1 Chain |
| 650 | 0 | 4 |
_aCollagen Type III _xgenetics |
| 650 | 0 | 4 |
_aCystatin C _xmetabolism |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aHypertension _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMyocardium _xmetabolism |
| 650 | 0 | 4 |
_aNADPH Oxidase 4 _xmetabolism |
| 650 | 0 | 4 |
_aNitric Oxide _xblood |
| 650 | 0 | 4 |
_aNitric Oxide Synthase Type III _xmetabolism |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 | _aRats, Inbred SHR |
| 650 | 0 | 4 | _aRats, Inbred WKY |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTroponin I _xblood |
| 650 | 0 | 4 |
_aWnt Signaling Pathway _xdrug effects |
| 700 | 1 | _aChen, Hua-Wen | |
| 700 | 1 | _aPi, Li-Juan | |
| 700 | 1 | _aWang, Jin | |
| 700 | 1 | _aZhan, Da-Qian | |
| 773 | 0 |
_tOncotarget _gvol. 8 _gno. 6 _gp. 10161-10170 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.14328 _zAvailable from publisher's website |
| 999 |
_c26753289 _d26753289 |
||